blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2293786

EP2293786 - Tablettable chewing gums comprising nicotine and a buffering agent [Right-click to bookmark this link]
Former [2011/11]TABLETTABLE CHEWING GUMS COMPRISING NICOTINE AND A BUFFERING AGENT
[2014/25]
StatusPatent revoked
Status updated on  16.03.2018
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  02.03.2017
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Novartis Consumer Health S.A.
Route de l'Etraz 2
1197 Prangins / CH
[2016/29]
Former [2011/11]For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / RUDOLPH, Markus
Hartmutweg 2
65843 Sulzbach (Taunus) / DE
02 / MARZANO, Giovanna
Chemin du Lynx 6
CH-1273 Arzier / CH
03 / RAULT, Isabelle
45, Impasse du Fontaillon
F-01170 Segny / FR
 [2011/13]
Former [2011/11]01 / RUDOLPH, Markus
Hartmutweg 2
65843 Sulzbach (Taunus) / DE
02 / MARZANO, Giovanna
Chemin du Lynx 6
CH-1273 Arzier / CH
03 / RAULT, Isabelle
45 Impasse du Fontaillon
F-01170 Segny / FR
Representative(s)Thompson, Clive Beresford, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2014/48]Bielefeldt, Florian, et al
Novartis Consumer Health S.A.
OTC Patents Group
Novartis Campus
Postfach
4002 Basel / CH
Former [2014/42]Bielefeldt, Florian, et al
Novartis Consumer Health S.A.
OCT Patents Group
Novartis Campus
Postfach
4002 Basel / CH
Former [2011/11]Liphardt, Bernd, et al
Novartis Consumer Health SA OTC Patent and Trademark Group Werk Rosental
4002 Basel / CH
Application number, filing date09749811.719.05.2009
[2011/11]
WO2009EP56032
Priority number, dateEP2008015663621.05.2008         Original published format: EP 08156636
[2011/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009141321
Date:26.11.2009
Language:EN
[2009/48]
Type: A2 Application without search report 
No.:EP2293786
Date:16.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 26.11.2009 takes the place of the publication of the European patent application.
[2011/11]
Type: B1 Patent specification 
No.:EP2293786
Date:26.11.2014
Language:EN
[2014/48]
Search report(s)International search report - published on:EP28.10.2010
ClassificationIPC:A61K9/68, A61K31/465, A61P25/34
[2011/11]
CPC:
A61K31/465 (EP,US); A61K47/26 (US); A61K47/46 (US);
A61K9/0058 (EP,US); A61P25/34 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/11]
TitleGerman:Tablettierbare Kaugummis enthaltend Nikotin sowie einen Puffer[2014/25]
English:Tablettable chewing gums comprising nicotine and a buffering agent[2014/25]
French:Gommes à mâcher pouvant être mises en comprimés comprenant de la nicotine et un agent tampon[2014/25]
Former [2011/11]TABLETTIERBARE KAUGUMMIS MIT NIKOTIN UND EINEM PUFFERUNGSMITTEL
Former [2011/11]TABLETTABLE CHEWING GUMS COMPRISING NICOTINE AND A BUFFERING AGENT
Former [2011/11]GOMMES À MÂCHER POUVANT ÊTRE MISES EN COMPRIMÉS COMPRENANT DE LA NICOTINE ET UN AGENT TAMPON
Entry into regional phase21.12.2010National basic fee paid 
28.04.2011Designation fee(s) paid 
28.04.2011Examination fee paid 
Examination procedure04.11.2010Amendment by applicant (claims and/or description)
28.04.2011Examination requested  [2011/23]
25.04.2013Despatch of a communication from the examining division (Time limit: M06)
24.10.2013Reply to a communication from the examining division
05.06.2014Communication of intention to grant the patent
14.10.2014Receipt of the translation of the claim(s)
15.10.2014Fee for grant paid
15.10.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.04.2013
Opposition(s)Opponent(s)01  25.08.2015    ADMISSIBLE
Fertin Pharma A/S
Dandyvej 19
DK-7100 Vejle / DK
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 [2015/42]
02.10.2015Invitation to proprietor to file observations on the notice of opposition
08.04.2016Reply of patent proprietor to notice(s) of opposition
31.01.2017Date of oral proceedings
03.03.2017Despatch of minutes of oral proceedings
03.03.2017Despatch of communication that the patent will be revoked
04.03.2018Legal effect of revocation of patent [2018/16]
Appeal following opposition28.04.2017Appeal received No.  T1048/17
20.02.2018Result of appeal procedure: appeal of the proprietor inadmissible
Fees paidRenewal fee
11.05.2011Renewal fee patent year 03
29.03.2012Renewal fee patent year 04
10.05.2013Renewal fee patent year 05
27.03.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.05.2009
AT26.11.2014
BE26.11.2014
BG26.11.2014
CH26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LI26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MK26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
TR26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
[2018/30]
Former [2018/21]HU19.05.2009
AT26.11.2014
BE26.11.2014
BG26.11.2014
CH26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LI26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
TR26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
Former [2017/46]HU19.05.2009
AT26.11.2014
BE26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
TR26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
Former [2017/39]HU19.05.2009
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
TR26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
Former [2017/03]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
Former [2016/20]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
IE19.05.2015
LU19.05.2015
Former [2016/12]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SI26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
LU19.05.2015
Former [2016/06]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
LU19.05.2015
Former [2016/03]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/37]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SK26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/36]AT26.11.2014
CY26.11.2014
CZ26.11.2014
EE26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RO26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/35]AT26.11.2014
CY26.11.2014
EE26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/26]AT26.11.2014
CY26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/25]AT26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/24]HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
GR27.02.2015
IS26.03.2015
Former [2015/23]LT26.11.2014
NL26.11.2014
IS26.03.2015
Former [2015/20]LT26.11.2014
Cited inInternational search[XDYI]WO2007104574  (NICONOVUM AB [SE], et al) [XD] 1-5,8,11-19 * page 3, line 1 - page 4, line 13 * * page 8, line 32 - page 9, line 2 * * page 10, line 32 - page 11, line 10 * * page 11, line 32 - page 13, line 21; examples 1,3,4 * * page 1, line 1 - page 2, line 23 * [Y] 9,10 [I] 6,7;
 [XDYI]WO2005023227  (PFIZER HEALTH AB [SE], et al) [XD] 1-6,13-19 * page 4, lines 10-21 * * page 13, lines 11-20 * * page 14, line 14 - page 15, line 26; example 6; table 9 * * claims 12-15 * [Y] 8-10 [I] 7;
 [XYI]US2004194793  (LINDELL KATARINA E A [SE], et al) [X] 1-6,8,13-19 * paragraph [0028] - paragraph [0032] * * paragraph [0262] * [Y] 9,10 [I] 7;
 [Y]US2002164398  (JOHNSON SONYA S [US], et al) [Y] 8-10 * example 7; table 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.